BECTON, DICKINSON AND COMPANY Cash Provided by (Used in) Financing Activities, Discontinued Operations
BECTON, DICKINSON AND COMPANY (BDX) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of -$3.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for the quarter ending 2026-06-30 was -$74.00M, a 2566.67% decline year-over-year.
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for the quarter ending 2025-06-30 was $3.00M.
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for the quarter ending 2023-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for the quarter ending 2023-06-30 was $0.00.
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for fiscal 2024 was $0.00.
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for fiscal 2022 was $145.00M.
- BECTON, DICKINSON AND COMPANY cash provided by (used in) financing activities, discontinued operations for fiscal 2021 was $0.00.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | -$3.00M 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $71.00M 10-Q · filed 2026-05-07 | |||
| 2025-06-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | -$3.00M 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $0.00 10-K · filed 2024-11-27 | |||
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $0.00 derived: sum of 2 quarters · filed 2024-11-27 | $0.00 10-K · filed 2024-11-27 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $0.00 derived: sum of 2 quarters · filed 2024-11-27 | $145.00M 10-K · filed 2024-11-27 | |
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-03 | $145.00M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $145.00M 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $0.00 10-K · filed 2023-11-21 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2020-09-30 | $0.00 10-K · filed 2022-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |